Perfect ALKemy: Optimizing the Use of ALK-Directed Therapies in Lung Cancer

per Politi, Katerina, Gettinger, Scott
Publicat a Clin Cancer Res (2014)

PD-1 axis inhibitors in EGFR and ALK Driven Lung Cancer: Lost cause?

per Gettinger, Scott, Politi, Katerina
Publicat a Clin Cancer Res (2016)

Current status of vandetanib (ZD6474) in the treatment of non-small cell lung cancer

per Flanigan, Jaclyn, Deshpande, Hari, Gettinger, Scott
Publicat 2010

Axitinib: The evidence of its potential in the treatment of advanced thyroid cancer

per Deshpande, Hari A, Gettinger, Scott, Sosa, Julie Ann
Publicat 2010

Immuno-thermal ablations – boosting the anticancer immune response

per Slovak, Ryan, Ludwig, Johannes M., Gettinger, Scott N., Herbst, Roy S., Kim, Hyun S.
Publicat a J Immunother Cancer (2017)

Late recurrence of basaloid carcinoma initially treated as a small cell lung cancer

per Shumaster, Vladimir, Bae, Jason W., Gettinger, Scott N., Cai, Guoping, Kim, Anthony W.
Publicat 2013

SOX2-specific adaptive immunity and response to immunotherapy in non-small cell lung cancer

per Dhodapkar, Kavita M, Gettinger, Scott N, Das, Rituparna, Zebroski, Henry, Dhodapkar, Madhav V
Publicat 2013

Oncolytic virus immunotherapy: future prospects for oncology

per Raja, Junaid, Ludwig, Johannes M., Gettinger, Scott N., Schalper, Kurt A., Kim, Hyun S.
Publicat a J Immunother Cancer (2018)

Precipitation of Autoimmune Diabetes With Anti-PD-1 Immunotherapy

per Hughes, Jing, Vudattu, Nalini, Sznol, Mario, Gettinger, Scott, Kluger, Harriet, Lupsa, Beatrice, Herold, Kevan C.
Publicat a Diabetes Care (2015)

Cryotherapy for nodal metastasis in NSCLC with acquired resistance to immunotherapy

per Adam, Lucas C., Raja, Junaid, Ludwig, Johannes M., Adeniran, Adebowale, Gettinger, Scott N., Kim, Hyun S.
Publicat a J Immunother Cancer (2018)

Distinct immunologic changes in vivo following combination versus individual PD-1 or CTLA-4 checkpoint blockade in human cancer

per Dhodapkar, Kavita, Verma, Rakesh, Sznol, Mario, Boddupalli, Chandra Sekhar, Gettinger, Scott, Kluger, Harriet, Dhodapkar, Madhav, Das, Rituparna
Publicat a J Immunother Cancer (2014)

An Advanced Practice Nurse Coordinated Multidisciplinary Intervention for Patients with Late-Stage Cancer: A Cluster Randomized Trial

per McCorkle, Ruth, Jeon, Sangchoon, Ercolano, Elizabeth, Lazenby, Mark, Reid, Amanda, Davies, Marianne, Viveiros, Diane, Gettinger, Scott
Publicat a J Palliat Med (2015)

Preliminary safety, pharmacokinetics, and efficacy of regorafenib, cisplatin, and pemetrexed in patients with advanced non-squamous non-small cell lung cancers

per Hellmann, Matthew D, Sturm, Isrid, Trnkova, Zuzana Jirakova, Lettieri, John, Diefenbach, Konstanze, Rizvi, Naiyer A., Gettinger, Scott N.
Publicat a Clin Lung Cancer (2015)

Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)

per Carvajal-Hausdorf, Daniel, Altan, Mehmet, Velcheti, Vamsidhar, Gettinger, Scott N., Herbst, Roy S., Rimm, David L., Schalper, Kurt A.
Publicat a J Immunother Cancer (2019)

Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non–Small Cell Lung Cancer

per Uhlig, Johannes, Case, Meaghan Dendy, Blasberg, Justin D., Boffa, Daniel J., Chiang, Anne, Gettinger, Scott N., Kim, Hyun S.
Publicat a JAMA Netw Open (2019)

Biomarkers associated with beneficial PD-1 checkpoint blockade in non-small-cell lung cancer (NSCLC) identified using high-plex digital spatial profiling

per Zugazagoitia, Jon, Gupta, Swati, Liu, Yuting, Fuhrman, Kit, Gettinger, Scott, Herbst, Roy, Schalper, Kurt A., Rimm, David L.
Publicat a Clin Cancer Res (2020)

High SOX2 Levels Predict Better Outcome in Non-Small Cell Lung Carcinomas

per Velcheti, Vamsidhar, Schalper, Kurt, Yao, Xiaopan, Cheng, Huan, Kocoglu, Mehmet, Dhodapkar, Kavita, Deng, Yanhong, Gettinger, Scott, Rimm, David L.
Publicat 2013

Treatment of Stage IV Non-small Cell Lung Cancer: Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

per Socinski, Mark A., Evans, Tracey, Gettinger, Scott, Hensing, Thomas A., VanDam Sequist, Lecia, Ireland, Belinda, Stinchcombe, Thomas E.
Publicat a Chest (2013)

Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy

per Suozzi, Kathleen C., Stahl, Maximilian, Ko, Christine J., Chiang, Anne, Gettinger, Scott N., Siegel, Mark D., Bunick, Christopher G.
Publicat a JAAD Case Rep (2016)

Clinical and Histologic Features of Lichenoid Mucocutaneous Eruptions Due to Anti–Programmed Cell Death 1 and Anti–Programmed Cell Death Ligand 1 Immunotherapy

per Shi, Veronica J., Rodic, Nemanja, Gettinger, Scott, Leventhal, Jonathan S., Neckman, Julia P., Girardi, Michael, Bosenberg, Marcus, Choi, Jennifer N.
Publicat a JAMA Dermatol (2016)